-
-
-
-
-
-
-
Clearmind Medicine files Japanese patent for depression treatment compound
-
-
-
-
-
-
-
Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications
-
-
-
-
-
-
-
Clearmind Medicine evaluates psychedelic drug for FDA breakthrough status
-
-
-
-
-
-
-
Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trial
-
-
-
-
-
-
-
Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use Disorder
-
-
-
-
-
-
-
Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline Results
-
-
-
-
-
-
-
Clearmind Medicine reports positive safety data for alcohol disorder drug
-
1,160,149 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

